TRAPS: Rivaroxaban versus warfarin for secondary prevention in antiphospholipid syndrome [Classics Series]

This study summary is an excerpt from 2 Minute Medicine’s book The Classics in Medicine: Summaries of the Landmark Trials 1. This study was discontinued prematurely due to excess thromboembolic and haemorrhage in patients treated with rivaroxaban compared to warfarin. 2. There were no deaths from thromboembolic or haemorrhage in either group. Original publication date: … Read more